Entheogenix Biosciences is a biotech company dedicated to advancing psychedelic research for the development of better medicines for mental health diseases such as depression, bipolar disorder, and schizophrenia. By harnessing the innovative power of artificial intelligence and computational biophysics, along with a data-driven pipeline, Entheogenix aims to uncover new medicines from desired psychedelics to further help patients.